Spencer Stonier is a Senior Director at Emergent BioSolutions with a strong background in research, product development, and technology development. Spencer has extensive experience in leading cross-functional teams, developing vaccines, managing immunoassay development, and assessing vaccine and drug candidates against infectious diseases. With a Doctorate in Immunology, Spencer has a proven track record of successful projects in the field of biotechnology and infectious diseases.
May 1, 2024 - present
September, 2023
October, 2021
June, 2020
January, 2020
November, 2018